Next Article in Journal
Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
Next Article in Special Issue
What Can Be Learned from the Early Stages of the COVID-19 Vaccination Rollout in Australia: A Case Study
Previous Article in Journal
Control of Canine Visceral Leishmaniasis: A Success Case Based on Deltamethrin 4% Collars
Previous Article in Special Issue
Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
Article

Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies

World Federation of Public Health Associations, 1202 Geneva, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editors: Michel Kazatchkine and Sana de Courcelles
Epidemiologia 2021, 2(4), 519-539; https://doi.org/10.3390/epidemiologia2040036
Received: 19 August 2021 / Revised: 26 September 2021 / Accepted: 20 October 2021 / Published: 23 October 2021
(This article belongs to the Special Issue Vaccination Strategies of COVID-19)
In late 2020 and early 2021, with the eagerly anticipated regulatory approval of vaccines against SARS-CoV-2, the urgent global effort to inoculate populations against this devastating virus was underway. These case studies examine the early stages of COVID-19 vaccine rollouts across nine regions from around the world (Brazil, India, Indonesia, Ireland, Israel, Nigeria, Taiwan, United Kingdom and United States). By evaluating and comparing different approaches used to immunize against a novel pathogen, it is possible to learn a great deal about which methods were successful, and in which areas strategies can be improved. This information is applicable to the ongoing global vaccination against this virus, as well as in the event of future pandemics. Research was conducted by following and tracking the progress of vaccine rollouts in the nine regions, using published clinical trials, government documents and news reports as sources of data. Results relate to the proportion of populations that had received at least one COVID-19 dose by 28 February 2021. Outcomes are discussed in the context of three key pillars integral to all immunization programs: procurement of vaccines, communication with the public and distribution of doses to individuals. View Full-Text
Keywords: COVID-19; vaccination; procurement; communication; distribution COVID-19; vaccination; procurement; communication; distribution
Show Figures

Figure 1

MDPI and ACS Style

Gannon, J.; Azari, R.; Lomazzi, M.; Borisch, B. Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies. Epidemiologia 2021, 2, 519-539. https://doi.org/10.3390/epidemiologia2040036

AMA Style

Gannon J, Azari R, Lomazzi M, Borisch B. Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies. Epidemiologia. 2021; 2(4):519-539. https://doi.org/10.3390/epidemiologia2040036

Chicago/Turabian Style

Gannon, John, Razieh Azari, Marta Lomazzi, and Bettina Borisch. 2021. "Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies" Epidemiologia 2, no. 4: 519-539. https://doi.org/10.3390/epidemiologia2040036

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop